Systematic Review of Therapeutic Physical Exercise in Patients with Amyotrophic Lateral Sclerosis over Time.
Ortega-Hombrados L, Molina-Torres G, Galán-Mercant A, Sánchez-Guerrero E, González-Sánchez M, Ruiz-Muñoz M.
Int J Environ Res Public Health. 2021 Jan 26;18(3):1074. doi: 10.3390/ijerph18031074.
Skeletal muscle in amyotrophic lateral sclerosis.
Shefner JM, Musaro A, Ngo ST, Lunetta C, Steyn FJ, Robitaille R, De Carvalho M, Rutkove S, Ludolph AC, Dupuis L.
Brain. 2023 Nov 2;146(11):4425-4436. doi: 10.1093/brain/awad202.
Effects of Exercise in Patients With Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis.
Meng L, Li X, Li C, Tsang RCC, Chen Y, Ge Y, Gao Q.
Am J Phys Med Rehabil. 2020 Sep;99(9):801-810. doi: 10.1097/PHM.0000000000001419.
Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
Miller RG, Mitchell JD, Moore DH.
Cochrane Database Syst Rev. 2012 Mar 14;2012(3):CD001447. doi: 10.1002/14651858.CD001447.pub3.
Safety and Effectiveness of Long-term Intravenous Administration of Edaravone for Treatment of Patients With Amyotrophic Lateral Sclerosis.
Witzel S, Maier A, Steinbach R, Grosskreutz J, Koch JC, Sarikidi A, Petri S, Günther R, Wolf J, Hermann A, Prudlo J, Cordts I, Lingor P, Löscher WN, Kohl Z, Hagenacker T, Ruckes C, Koch B, Spittel S, Günther K, Michels S, Dorst J, Meyer T, Ludolph AC; German Motor Neuron Disease Network (MND-NET).
JAMA Neurol. 2022 Feb 1;79(2):121-130. doi: 10.1001/jamaneurol.2021.4893.
Therapeutic exercise for people with amyotrophic lateral sclerosis or motor neuron disease.
Dal Bello-Haas V, Florence JM.
Cochrane Database Syst Rev. 2013 May 31;2013(5):CD005229. doi: 10.1002/14651858.CD005229.pub3.
A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group.
Bensimon G, Lacomblez L, Meininger V.
N Engl J Med. 1994 Mar 3;330(9):585-91. doi: 10.1056/NEJM199403033300901.
Efficacy of non-pharmacological interventions for individuals with amyotrophic lateral sclerosis: systematic review and network meta-analysis of randomized control trials.
Li Z, Kang H.
Sci Rep. 2024 May 18;14(1):11365. doi: 10.1038/s41598-024-62213-w.
Physical therapy for the management of global function, fatigue and quality of life in amyotrophic lateral sclerosis: systematic review and meta-analyses.
Silva ST, Costa IM, Souza AA, Pondofe K, Melo LP, Resqueti VR, Valentim R, Gonçalves F, Ribeiro TS.
BMJ Open. 2024 Aug 25;14(8):e076541. doi: 10.1136/bmjopen-2023-076541.
Secondary Metabolites with Antioxidant Activities for the Putative Treatment of Amyotrophic Lateral Sclerosis (ALS): "Experimental Evidences".
Silva JM, Nobre MSC, Albino SL, Lócio LL, Nascimento APS, Scotti L, Scotti MT, Oshiro-Junior JA, Lima MCA, Mendonça-Junior FJB, Moura RO.
Oxid Med Cell Longev. 2020 Nov 24;2020:5642029. doi: 10.1155/2020/5642029. eCollection 2020.
